This clearly outlines the positive trajectory of the company and technology. Robert was MD, CEO and Chairman of the $4 billion mammoth pathology giant for nearly 7 years.. Obviously he sees the immense potential here and is keen to attach his name to the company and technology.
It's a game changer in so many ways because it's direct competitor are pathologies - they obviously want some involvement in this emerging industry shattering technology or they'll be left exposed.
We're just getting started. Oral and breast cancer applications are only the beginning. The potential is mind numbing and likewise the benefit to patients.
EX CEO of HEALTHSCOPE, page-5
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $146.1M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 16.5¢ | $16.50K | 97.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 168328 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 27434 | 3 |
View Market Depth
| Last trade - 11.27am 04/10/2024 (20 minute delay) ? |
| OIL (ASX) Chart |